Reply to Roberts et al.: CHEERS is sufficient for reporting cost-benefit analysis, but may require further elaboration

Josephine A. Mauskopf; D Husereau; Michael F  Drummond; S Petrou; D Greenberg; Jo Mauskopf; F Augustovski; A Briggs; D Moher; E Loder; C Carswell

Reply to Roberts et al.: CHEERS is sufficient for reporting cost-benefit analysis, but may require further elaboration

Husereau, D., Drummond, M., Petrou, S., Greenberg, D., Mauskopf, J., Augustovski, F., Briggs, A., Moher, D., Loder, E., & Carswell, C. (2015). Reply to Roberts et al.: CHEERS is sufficient for reporting cost-benefit analysis, but may require further elaboration. PharmacoEconomics, 33(5), 535-536. https://doi.org/10.1007/s40273-015-0277-8

Copy citation